BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21841210)

  • 1. Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated ¹⁸⁶Re radionuclides.
    Hrycushko BA; Ware S; Li S; Bao A
    Phys Med Biol; 2011 Sep; 56(17):5721-34. PubMed ID: 21841210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution.
    Hrycushko BA; Li S; Goins B; Otto RA; Bao A
    Med Phys; 2011 Mar; 38(3):1339-47. PubMed ID: 21520844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide.
    French JT; Goins B; Saenz M; Li S; Garcia-Rojas X; Phillips WT; Otto RA; Bao A
    J Vasc Interv Radiol; 2010 Aug; 21(8):1271-9. PubMed ID: 20478719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides.
    Hrycushko BA; Gutierrez AN; Goins B; Yan W; Phillips WT; Otto PM; Bao A
    Phys Med Biol; 2011 Feb; 56(3):703-19. PubMed ID: 21299006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model.
    Wang SX; Bao A; Herrera SJ; Phillips WT; Goins B; Santoyo C; Miller FR; Otto RA
    Clin Cancer Res; 2008 Jun; 14(12):3975-83. PubMed ID: 18559620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
    Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
    Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response.
    Soundararajan A; Bao A; Phillips WT; McManus LM; Goins BA
    Cancer Biother Radiopharm; 2011 Oct; 26(5):603-14. PubMed ID: 21834653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.
    Soundararajan A; Dodd GD; Bao A; Phillips WT; McManus LM; Prihoda TJ; Goins BA
    Radiology; 2011 Dec; 261(3):813-23. PubMed ID: 22025735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EUD-based biological optimization for carbon ion therapy.
    Brüningk SC; Kamp F; Wilkens JJ
    Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From physical dose constraints to equivalent uniform dose constraints in inverse radiotherapy planning.
    Thieke C; Bortfeld T; Niemierko A; Nill S
    Med Phys; 2003 Sep; 30(9):2332-9. PubMed ID: 14528955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas.
    Chatterjee S; Willis N; Locks SM; Mott JH; Kelly CG
    Br J Radiol; 2011 Dec; 84(1008):1083-90. PubMed ID: 22101580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
    Song W; Battista J; Van Dyk J
    Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes.
    Hrycushko BA; Li S; Shi C; Goins B; Liu Y; Phillips WT; Otto PM; Bao A
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):948-55. PubMed ID: 20864271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose.
    Wu Q; Mohan R; Niemierko A; Schmidt-Ullrich R
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):224-35. PubMed ID: 11777642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model.
    Soundararajan A; Bao A; Phillips WT; Perez R; Goins BA
    Nucl Med Biol; 2009 Jul; 36(5):515-24. PubMed ID: 19520292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial dose distributions in solid tumors from 186Re transported by liposomes using HS radiochromic media.
    Medina LA; Goins B; Rodríguez-Villafuerte M; Bao A; Martínez-Davalos A; Awasthi V; Galván OO; Santoyo C; Phillips WT; Brandan ME
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1039-49. PubMed ID: 17287961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.
    Li XA; Wang JZ; Stewart RD; DiBiase SJ
    Phys Med Biol; 2003 Sep; 48(17):2753-65. PubMed ID: 14516099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.
    Cozzi L; Fogliata A; Lomax A; Bolsi A
    Radiother Oncol; 2001 Dec; 61(3):287-97. PubMed ID: 11730999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.